Kyle Mikson
Stock Analyst at Canaccord Genuity
(2.23)
# 2,910
Out of 5,149 analysts
124
Total ratings
39.58%
Success rate
-0.79%
Average return
Main Sectors:
Stocks Rated by Kyle Mikson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Buy | $125 → $135 | $93.30 | +44.69% | 11 | Feb 20, 2026 | |
| GRAL GRAIL | Maintains: Buy | $105 → $80 | $52.76 | +51.63% | 6 | Feb 20, 2026 | |
| BDSX Biodesix | Maintains: Buy | $20 | $15.50 | +29.03% | 6 | Feb 17, 2026 | |
| ILMN Illumina | Maintains: Hold | $130 → $150 | $129.56 | +15.78% | 15 | Jan 26, 2026 | |
| WGS GeneDx Holdings | Maintains: Buy | $160 → $170 | $76.97 | +120.87% | 3 | Dec 22, 2025 | |
| TXG 10x Genomics | Maintains: Buy | $19 → $20 | $22.62 | -11.58% | 10 | Dec 22, 2025 | |
| TEM Tempus AI | Maintains: Buy | $95 → $80 | $51.40 | +55.64% | 3 | Dec 22, 2025 | |
| QTRX Quanterix | Maintains: Hold | $5 → $8 | $5.87 | +36.29% | 8 | Dec 22, 2025 | |
| QSI Quantum-Si incorporated | Maintains: Hold | $2 → $1.5 | $0.95 | +58.23% | 6 | Dec 22, 2025 | |
| NTRA Natera | Maintains: Buy | $250 → $285 | $207.04 | +37.65% | 12 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $37 → $50 | $27.57 | +81.36% | 6 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $28 → $30 | $19.38 | +54.80% | 2 | Dec 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $85 → $105 | $103.37 | +1.58% | 10 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $40 → $43 | $35.08 | +22.58% | 2 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $150 → $165 | $123.06 | +34.08% | 4 | Oct 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $15 | $3.43 | +337.32% | 5 | Oct 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.52 | +97.37% | 8 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 | $1.45 | +106.90% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $3 → $2 | $0.20 | +899.50% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,476 | $10.15 | +14,441.87% | 1 | Mar 30, 2021 |
Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $125 → $135
Current: $93.30
Upside: +44.69%
GRAIL
Feb 20, 2026
Maintains: Buy
Price Target: $105 → $80
Current: $52.76
Upside: +51.63%
Biodesix
Feb 17, 2026
Maintains: Buy
Price Target: $20
Current: $15.50
Upside: +29.03%
Illumina
Jan 26, 2026
Maintains: Hold
Price Target: $130 → $150
Current: $129.56
Upside: +15.78%
GeneDx Holdings
Dec 22, 2025
Maintains: Buy
Price Target: $160 → $170
Current: $76.97
Upside: +120.87%
10x Genomics
Dec 22, 2025
Maintains: Buy
Price Target: $19 → $20
Current: $22.62
Upside: -11.58%
Tempus AI
Dec 22, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $51.40
Upside: +55.64%
Quanterix
Dec 22, 2025
Maintains: Hold
Price Target: $5 → $8
Current: $5.87
Upside: +36.29%
Quantum-Si incorporated
Dec 22, 2025
Maintains: Hold
Price Target: $2 → $1.5
Current: $0.95
Upside: +58.23%
Natera
Dec 22, 2025
Maintains: Buy
Price Target: $250 → $285
Current: $207.04
Upside: +37.65%
Dec 22, 2025
Maintains: Buy
Price Target: $37 → $50
Current: $27.57
Upside: +81.36%
Dec 22, 2025
Maintains: Hold
Price Target: $28 → $30
Current: $19.38
Upside: +54.80%
Nov 25, 2025
Downgrades: Hold
Price Target: $85 → $105
Current: $103.37
Upside: +1.58%
Nov 5, 2025
Maintains: Hold
Price Target: $40 → $43
Current: $35.08
Upside: +22.58%
Oct 29, 2025
Maintains: Hold
Price Target: $150 → $165
Current: $123.06
Upside: +34.08%
Oct 27, 2025
Maintains: Buy
Price Target: $11 → $15
Current: $3.43
Upside: +337.32%
Apr 10, 2025
Maintains: Buy
Price Target: $3
Current: $1.52
Upside: +97.37%
Nov 14, 2024
Maintains: Buy
Price Target: $3
Current: $1.45
Upside: +106.90%
Aug 16, 2023
Maintains: Overweight
Price Target: $3 → $2
Current: $0.20
Upside: +899.50%
Mar 30, 2021
Initiates: Overweight
Price Target: $1,476
Current: $10.15
Upside: +14,441.87%